Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/102744
Full metadata record
DC FieldValueLanguage
dc.contributor.authorD'Anastasi, Melvin-
dc.contributor.authorEbenberger, Simone-
dc.contributor.authorAlghamdi, Abdulmajeed-
dc.contributor.authorHelck, Andreas-
dc.contributor.authorHerlemann, Annika-
dc.contributor.authorStief, Christian-
dc.contributor.authorKhoder, Wael-
dc.contributor.authorTrumm, Christoph G.-
dc.contributor.authorStahl, Robert-
dc.date.accessioned2022-10-17T10:00:48Z-
dc.date.available2022-10-17T10:00:48Z-
dc.date.issued2022-
dc.identifier.citationD’Anastasi, M., Ebenberger, S., Alghamdi, A., Helck, A., Herlemann, A., Stief, C.,...Stahl, R. (2022). Technical Outcome, Clinical Success, and Complications of Low-Milliampere Computed Tomography Fluoroscopy-Guided Drainage of Lymphoceles Following Radical Prostatectomy with Pelvic Lymph Node Dissection. Diagnostics, 12(10), 2394.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/102744-
dc.description.abstractTo evaluate the technical outcome, clinical success, and safety of low-milliampere CT fluoroscopy (CTF)-guided percutaneous drain (PD) placement in patients with lymphoceles following radical prostatectomy (RP) with pelvic lymph node dissection (LND). This retrospective analysis comprised 65 patients with PD placement in lymphoceles following RP under low-milliampere CTF guidance. Technical and clinical success were evaluated. Complications within a 30-day time interval associated with CTF-guided PD placement were classified according to SIR. Patient radiation exposure was quantified using dose-length products (DLP) of the pre-interventional planning CT scan (DLPpre), of the sum of intra-interventional CT fluoroscopic acquisitions (DLPintra) and of the post-interventional control CT scan (DLPpost). Eighty-nine lymphoceles were detected. Seventy-seven CT-guided interventions were performed, with a total of 92 inserted drains. CTF-guided lymphocele drainage was technically successful in 100% of cases. For all symptomatic patients, improvement in symptoms was reported within 48 h after intervention. Time course of C-reactive protein and Leucocytes within 30 days revealed a statistically significant (p < 0.0001) decrease. Median DLPpre, DLPintra and DLPpost were 431 mGy*cm, 45 mGy*cm and 303 mGy*cm, respectively. Only one minor complication (self-resolving haematoma over the bladder dome; SIR Grade 2) was observed. Low-milliampere CTF-guided drainage is a safe treatment option in patients with lymphoceles following RP with pelvic LND characterized by high technical and good clinical success rates, which provides rapid symptom relief and serves as definite treatment or as a bridging therapy prior to laparoscopic marsupialisation.en_GB
dc.language.isoenen_GB
dc.publisherMDPIen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectLymphoceleen_GB
dc.subjectPelvis -- Lymphatics -- Tomographyen_GB
dc.subjectDiagnosis, Fluoroscopicen_GB
dc.subjectMultidetector computed tomographyen_GB
dc.subjectProstatectomy -- Complicationsen_GB
dc.titleTechnical outcome, clinical success, and complications of low-milliampere computed tomography fluoroscopy-guided drainage of lymphoceles following radical prostatectomy with pelvic lymph node dissectionen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedpeer-revieweden_GB
dc.identifier.doi10.3390/diagnostics12102394-
dc.publication.titleDiagnosticsen_GB
Appears in Collections:Scholarly Works - FacM&SCRNM



Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.